Kadans Science Partner has secured a letting with oncology and haematology clinical development company Oncostrata at the London Innovation Centre in Canary Wharf.
Oncostrata is a UK-based company working with global biotech and pharmaceutical clients to provide guidance across the full lifecycle of clinical development, from clinical trial design and scientific oversight to regulatory documentation and health authority submissions.
The London Innovation Centre, which is located at 20 Water Street, comprises 40,000 sq ft of laboratory space, flexible CL2 wet labs and bespoke offices and meeting rooms.
Joanna Hanks, founder and head of clinical science at Oncostrata, said: “We are very excited to be a part of the London Innovation Centre. The energy and enthusiasm is evident and ideas flow freely, being embedded within a wider network of world leading labs and university hospitals is also incredibly inspiring. We’ve already begun engaging with teams who share our commitment to oncology innovation, and an enthusiasm to advance preclinical ideas into the clinical stage. A clear pathway to first-in-humans clinical trials is where we can help early biotechs and we’re excited about the possibilities these initial conversations are unlocking.”
Katie Nelson, head of leasing UK and Ireland at Kadans Science Partner, added: “Oncostrata’s presence at the London Innovation Centre at Canary Wharf strengthens Kadans’ growing pan-European life sciences network. The company’s expertise in oncology clinical development will further enhance the centre’s mission to support early-stage innovators by providing access to the resources, infrastructure and collaborative environment needed to bring new ideas to fruition and accelerate progress.”
